Atomwise (YC W15) Discovers Drugs For Diseases That Don’t Even Exist Yet

by Y Combinator3/6/2015

“Here I am just sitting in this house and I’m able to predict a cure to measles,” co-founder of Atomwise Alex Levy tells me over the phone from his apartment in Mountain View, Calif.

Atomwise, a health tech startup in the current Y Combinator batch, has launched more than a dozen projects in the last year to find cures for both common and orphan diseases – diseases that would otherwise be too expensive and time-intensive to tackle. It’s working with IBM to find a cure to Ebola and with Dalhousie University in Canada to search for a measles treatment. Levy says the startup went through 8.2 million compounds to find potential cures for multiple sclerosis in a matter of days.”

Read the full story on TechCrunch

Author

  • Y Combinator

    Y Combinator created a new model for funding early stage startups. Twice a year we invest a small amount of money ($150k) in a large number of startups (recently 200). The startups move to Silicon